Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Oxygen therapy harms lungs via lung, gut microbiome

Aug. 19, 2020

Interim analysis data from ODYSSEY study of tradipitant in COVID-19 pneumonia

Aug. 18, 2020

Improved oxygenation observed in COVID-19 patients treated with icatibant

Aug. 18, 2020

Clinical improvement seen with anti-MASP-2 monoclonal antibody narsoplimab in COVID-19 patients

Aug. 14, 2020

Nirsevimab prevents RSV-associated lower respiratory tract infections in preterm infants

Aug. 14, 2020

First patient enrolled in phase III InPedILD study of nintedanib

Aug. 13, 2020

Notable responses seen in COVID-19 patients with respiratory failure given RLF-100

Aug. 13, 2020

AnaptysBio reports interim analysis data from ECLIPSE phase II study of etokimab

Aug. 11, 2020

Bayer begins phase II study of inhaled PEGylated adrenomedullin in ARDS

Aug. 11, 2020

Boehringer Ingelheim initiates phase II study of BI-1015550 in IPF

Aug. 10, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...